Intermolecular (IMI) Reports In-Line Q4 EPS, Offers Q1 Guidance

Intermolecular (NASDAQ: IMI) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.5 million.

GUIDANCE:

Intermolecular sees Q1 2019 EPS of ($0.04)-($0.05), versus the consensus of ($0.04). Intermolecular sees Q1 2019 revenue of $6.1-6.5 million, versus the consensus of $6.8 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
• Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance